Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease

Experimental Neurology

Volumn 162, Issue 2, 2000, Pages 328-342

  Menalled, Liliana ^a   Zanjani, Hadi ^a   MacKenzie, Larami ^a   Koppel, Ahrin ^b   Carpenter, Ellen ^b   Zeitlin, Scott ^c   Chesselet, Marie Francoise ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Enkephalin; Huntington's disease; Immunohistochemistry; In situ hybridization; In situ nick translation; Neurodegenerative disease; Striatum; Transgenic mice

Indexed keywords

CALBINDIN; CHOLINE ACETYLTRANSFERASE; ENKEPHALIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE; HUNTINGTIN; MESSENGER RNA; PARVALBUMIN; SOMATOSTATIN; SUBSTANCE P; UBIQUITIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CORPUS STRIATUM; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RNA ANALYSIS;

EID: 0034048845     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7327     Document Type: Article

References (66)

1. Albin R. L., Qin Y., Young A. B., Penney J. B., Chesselet M.-F. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: An in situ hybridization study. Ann. Neurol. 30:1991;542-549.
2. Albin R. L., Reiner A., Anderson K. D., Dure L. S., Handelin B., Balfour R., J. W. O., Penney J. B., Young A. B. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann. Neurol. 31:1992;425-430.
3. Albin R. L., Young A. B., Penney J. B. The functional anatomy of basal ganglia disorders [see comments]. Trends Neurosci. 12:1989;366-375.
4. Albin R. L., Young A. B., Penney J. B., Handelin B., Balfour R., Anderson K. D., Markel D. S., Tourtellotte W. W., Reiner A. Abnormalities of striatal projection neurons and N-methyl-d-aspartate receptors in presymptomatic Huntington's disease [see comments]. N. Engl. J. Med. 322:1990;1293-1298.
5. Alexander G. E., Crutcher M. D. Functional architecture of basal ganglia circuits: Neural substrates of parallel processing [see comments]. Trends Neurosci. 13:1990;266-271.
6. Beal M. F., Ferrante R. J., Swartz K. J., Kowall N. W. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11:1991;1649-1659.
7. Bolam J. P., Bennett B. D. Microcircuitry of the neostriatum. Ariano M. A., Surmeier D. J. Molecular and Cellular Mechanisms of Neostriatal Function. 1995;1-20 R. G. Landes, Austin.
8. Bordelon Y. M., Chesselet M.-F. Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia. Neuroscience. 93:1999;843-853.
9. Carter R. J., Lione L. A., Humby T., Mangiarini L., Mahal A., Bates G. P., Dunnett S. B., Morton A. J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19:1999;3248-3257.
10. Cha J. H., Kosinski C. M., Kerner J. A., Alsdorf S. A., Mangiarini L., Davies S. W., Penney J. B., Bates G. P., Young A. B. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene. Proc. Natl. Acad. Sci. USA. 95:1998;6480-6485.
11. Chen J., Jin K., Chen M., Pei W., Kawaguchi K., Greenberg D. A., Simon R. P. Early detection of DNA strand breaks in the brain after transient focal ischemia: Implications for the role of DNA damage in apoptosis and neuronal cell death. J. Neurochem. 69:1997;232-245.
12. Chesselet, M.-F. 1996. Quantitative analysis and interpretation of data for in situ hybridization at the cellular level. Pages 141-149 in B. Z. Henderson, Ed., In Situ Hybridization Techniques for the Brain, Vol. IBRO, Handbook Series: Methods in the Neurosciences. Wiley, West Sussex.
13. Chesselet M.-F. Mapping the basal ganglia. Toga A. W., Mazziotta J. C. Brain Mapping: The Applications. 1999;Academic Press.
14. Chesselet M. F., Weiss L., Wuenschell C., Tobin A. J., Affolter H. U. Comparative distribution of mRNAs for glutamic acid decarboxylase, tyrosine hydroxylase, and tachykinins in the basal ganglia: An in situ hybridization study in the rodent brain. J. Comp. Neurol. 262:1987;125-140.
15. Cuello A. C., Fiacco M. Del, Paxinos G., Somogyi P., Priestley J. V. Neuropeptides in striato-nigral pathways. J. Neural Transm. 51:1981;83-96.
16. Davies S. W., Turmaine M., Cozens B. A., DiFiglia M., Sharp A. H., Ross C. A., Scherzinger E., Wanker E. E., Mangiarini L., Bates G. P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 90:1997;537-548.
17. Del Fiacco M., Paxinos G., Cuello A. C. Neostriatal enkephalin-immunoreactive neurones project to the globus pallidus. Brain Res. 231:1982;1-17.
18. Didier M., Bursztajn S., Adamec E., Passani L., Nixon R. A., Coyle J. T., Wei J. Y., Berman S. A. DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures. J. Neurosci. 16:1996;2238-2250.
19. DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E., Vonsattel J., Carraway R., Reeves S. A. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron. 14:1995;1075-1081.
20. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 277:1997;1990-1993.
21. Erlander M. G., Tillakaratne N. J., Feldblum S., Patel N., Tobin A. J. Two genes encode distinct glutamate decarboxylases. Neuron. 7:1991;91-100.
22. Ferrante R. J., Beal M. F., Kowall N. W., J. E. P., Martin J. B. Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Res. 411:1987;162-166.
23. Ferrante R. J., Kowall N. W., Beal M. F., Martin J. B., Bird E. D., J. E. P. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 46:1987;12-27.
24. Ferrante R. J., Kowall N. W., Beal M. F., J. E. P., Bird E. D., Martin J. B. Selective sparing of a class of striatal neurons in Huntington's disease. Science. 230:1985;561-563.
25. Ferrante R. J., Kowall N. W., Cipolloni P. B., Storey E., Beal M. F. Excitotoxin lesions in primates as a model for Huntington's disease: Histopathologic and neurochemical characterization. Exp. Neurol. 119:1993;46-71.
26. Franklin K. B. J., Paxinos G. The Mouse Brain Coordinates in Stereotaxic Coordinates. 1997;Academic Press, San Diego.
27. Gerfen C. R., Baimbridge K. G., Miller J. J. The neostriatal mosaic: Compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc. Natl. Acad. Sci. USA. 82:1985;8780-8784.
28. Gerfen C. R., Young W. S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: An in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460:1988;161-167.
29. Gold R., Schmied M., Giegerich G., Breitschopf H., Hartung H. P., Toyka K. V., Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques [see comments]. Lab. Invest. 71:1994;219-225.
30. Graybiel A. M. The basal ganglia. Trends Neurosci. 18:1995;60-62.
31. Haber S., Elde R. The distribution of enkephalin immunoreactive fibers and terminals in the monkey central nervous system: An immunohistochemical study. Neuroscience. 7:1982;1049-1095.
32. Harper P. S. Huntington's Disease. 1996;Saunders, London/Philadelphia.
33. Harrington K. M., Kowall N. W. Parvalbumin immunoreactive neurons resist degeneration in Huntington's disease striatum. J. Neuropathol. Exp. Neurol. 50:1991;309.
34. Hayden M. R., Martin W. R., Stoessl A. J., Clark C., Hollenberg S., Adam M. J., Ammann W., Harrop R., Rogers J., Ruth T., Sayre C., Pate B. D. Positron emission tomography in the early diagnosis of Huntington's disease. Neurology. 36:1986;888-894.
35. Hoover B. R., Marshall J. F. Population characteristics of preproenkephalin mRNA-containing neurons in the globus pallidus of the rat. Neurosci. Lett. 265:1999;199-202.
36. Cell. 72:1993;971-983.
37. Iseki S., Mori T. Histochemical detection of DNA strand scissions in mammalian cells by in situ nick translation. Cell Biol. Int. Rep. 9:1985;471-477.
38. 1H NMR spectroscopy. Neurology. 43:1993;2689-2695.
39. Kaufman D. L., McGinnis J. F., Krieger N. R., Tobin A. J. Brain glutamate decarboxylase cloned in lambda gt-11: Fusion protein produces gamma-aminobutyric acid. Science. 232:1986;1138-1140.
40. Kawaguchi Y., Wilson C. J., Augood S. J., Emson P. C., C P. Striatal interneurones: Chemical, physiological and morphological characterization. Trends Neurosci. 18:1995;527-535.
41. Kawaguchi Y., Wilson C. J., Emson P. C. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J. Neurosci. 10:1990;3421-3438.
42. Krause J. E., Chirgwin J. M., Carter M. S., Xu Z. S., Hershey A. D. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. Natl. Acad. Sci. USA. 84:1987;881-885.
43. Kuhl D. E., Metter E. J., Riege W. H., Markham C. H. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease. Ann. Neurol. 15:1984;S119-125.
44. Laprade N., Soghomonian J. J. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum. Brain Res. Mol. Brain Res. 34:1995;65-74.
45. Levine M. S., Chesselet M.-F., Koppel A., Gruen E., Cepeda C., Carpenter E. M., Zanjani H., Hurst R. S., Altemus K. L., Murai J. S., Efstratiadis A., Zeitlin S. Enhanced sensitivity to glutamate receptor activation in mouse models of Huntington's disease. Soc. Neurosci. Abstr. 24:1998;972.
46. Levine M. S., Klapstein G. J., Koppel A., Gruen E., Cepeda C., Vargas M. E., Jokel E. S., Carpenter E. M., Zanjani H., Hurst R. S., Efstratiadis A., Zeitlin S., Chesselet M.-F. Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. J. Neurosci. Res. 58:1999;515-532.
47. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S. W., Bates G. P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87:1996;493-506.
48. Maniatis T., Fritsch E. F., Sambrook P. Molecular Cloning: A Laboratory Manual. 1982;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
49. Mercugliano M., Soghomonian J. J., Qin Y., Nguyen H. Q., Feldblum S., Erlander M. G., Tobin A. J., Chesselet M. F. Comparative distribution of messenger RNAs encoding glutamic acid decarboxylases (Mr 65,000 and Mr 67,000) in the basal ganglia of the rat. J. Comp. Neurol. 318:1992;245-254.
50. Myers R. H., Vonsattel J. P., Stevens T. J., Cupples L. A., Richardson E. P., Martin J. B., Bird E. D. Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology. 38:1988;341-347.
51. Reiner A., Albin R. L., Anderson K. D., D'Amato C. J., Penney J. B., Young A. B. Differential loss of striatal projection neurons in Huntington disease. Proc. Natl. Acad. Sci. USA. 85:1988;5733-5737.
52. Reynolds G. P., Dalton C. F., Tillery C. L., Mangiarini L., Davies S. W., Bates G. P. Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation. J. Neurochem. 72:1999;1773-1776.
53. Richfield E. K., Herkenham M. Selective vulnerability in Huntington's disease: Preferential loss of cannabinoid receptors in lateral globus pallidus. Ann. Neurol. 36:1994;577-584.
54. Richfield E. K., Maguire-Zeiss K. A., Vonkeman H. E., Voorn P. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients [see comments]. Ann. Neurol. 38:1995;852-861.
55. Salin P., Chesselet M.-F. Paradoxical increase in striatal neuropeptide gene expression following ischemic lesions of the cerebral cortex. Proc. Natl. Acad. Sci. USA. 89:1992;9954-9958.
56. Sapp E., Ge P., Aizawa H., Bird E., Penney J., Young A. B., Vonsattel J. P., DiFiglia M. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience. 64:1995;397-404.
57. Saudou F., Finkbeiner S., Devys D., Greenberg M. E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 95:1998;55-66.
58. Shelbourne P. F., Killeen N., Hevner R. F., Johnston H. M., Tecott L., Lewandoski M., Ennis M., Ramirez L., Li Z., Iannicola C., Littman D. R., Myers R. M. A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum. Mol. Genet. 8:1999;763-774.
59. Simantov R., Kuhar M. J., Uhl G. R., Snyder S. H. Opioid peptide enkephalin: Immunohistochemical mapping in rat central nervous system. Proc. Natl. Acad. Sci. USA. 74:1977;2167-2171.
60. Usdin M. T., Shelbourne P. F., Myers R. M., Madison D. V. Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Hum. Mol. Genet. 8:1999;839-846.
61. Velier J., Kim M., Schwarz C., Kim T. W., Sapp E., Chase K., Aronin N., DiFiglia M. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp. Neurol. 152:1998;34-40.
62. Vonsattel J. P., DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57:1998;369-384.
63. Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D., J. E. P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44:1985;559-577.
64. White J. K., Auerbach W., Duyao M. P., Vonsattel J. P., Gusella J. F., Joyner A. L., MacDonald M. E. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat. Genet. 17:1997;404-410.
65. Yoshikawa K., Williams C., Sabol S. L. Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. J. Biol. Chem. 259:1984;14301-14308.
66. Young A. B., Penney J. B., Starosta-Rubinstein S., Markel D., Berent S., Rothley J., Betley A., Hichwa R. Normal caudate glucose metabolism in persons at risk for Huntington's disease. Arch. Neurol. 44:1987;254-257.